AMLX
NASDAQ · Pharmaceuticals
Amylyx Pharmaceuticals Inc
$32.91
-0.09 (-0.27%)
Open$32.89
Previous Close$33.00
Day High$33.03
Day Low$32.69
52W High$41.14
52W Low$10.83
Volume—
Avg Volume1.54M
Market Cap4.10B
P/E Ratio—
EPS$-1.43
SectorPharmaceuticals
Analyst Ratings
Strong Buy
18 analysts
Price Target
+12.9% upside
Current
$32.91
$32.91
Target
$37.15
$37.15
$28.49
$37.15 avg
$49.81
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 140.51M | 449.35M | 403.13M |
| Net Income | -485,264,659 | 64.17M | 62.78M |
| Profit Margin | -345.4% | 14.3% | 15.6% |
| EBITDA | -506,644,708 | 107.91M | 96.37M |
| Free Cash Flow | — | 81.20M | 53.03M |
| Rev Growth | +574.3% | +13.9% | +9.9% |
| Debt/Equity | — | 0.29 | 0.32 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,148.51 | -1.85% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $267.76 | -0.53% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $147.66 | -2.15% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $28.05 | +0.43% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.77 | -1.50% | 11.5 | 30.15B |